| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
ID: ALA4793593
Max Phase: Preclinical
Molecular Formula: C16H19N7O
Molecular Weight: 325.38
Molecule Type: Unknown
Associated Items:
Representations
Canonical SMILES: COc1ccc(-n2nnc3cnc(N[C@H]4CC[C@H](N)C4)nc32)cc1
Standard InChI: InChI=1S/C16H19N7O/c1-24-13-6-4-12(5-7-13)23-15-14(21-22-23)9-18-16(20-15)19-11-3-2-10(17)8-11/h4-7,9-11H,2-3,8,17H2,1H3,(H,18,19,20)/t10-,11-/m0/s1
Standard InChI Key: OSHLPUOBFBCDRP-QWRGUYRKSA-N
Associated Targets(Human)
Mitogen-activated protein kinase 6 562 Activities
Molecule Features
| Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
| Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
| Chirality: No | Availability: No | Prodrug: No |
Drug Indications
| MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
|---|
Mechanisms of Action
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
Properties
| Molecular Weight: 325.38 | Molecular Weight (Monoisotopic): 325.1651 | AlogP: 1.51 | #Rotatable Bonds: 4 |
| Polar Surface Area: 103.77 | Molecular Species: BASE | HBA: 8 | HBD: 2 |
| #RO5 Violations: 0 | HBA (Lipinski): 8 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): 0 |
| CX Acidic pKa: | CX Basic pKa: 10.06 | CX LogP: 1.31 | CX LogD: -1.20 |
| Aromatic Rings: 3 | Heavy Atoms: 24 | QED Weighted: 0.75 | Np Likeness Score: -1.41 |
References
| 1. Grädler U,Busch M,Leuthner B,Raba M,Burgdorf L,Lehmann M,Linde N,Esdar C. (2020) Biochemical, cellular and structural characterization of novel and selective ERK3 inhibitors., 30 (22): [PMID:32927028] [10.1016/j.bmcl.2020.127551] |
Source
Source(1):